UPDATE : Monday, September 7, 2020
상단여백
Korea’s share remains small in multinational pharmaceuticals’ operation
What is the proportion of the Korean market among multinational pharmaceuti...
by Marian Chu and Nam Doo-hyun  |  2017-05-09 02:53
라인
Can Jardiance threaten Forxiga's dominance in treating diabetes?
Korean regulators have officially recognized the effect of SGLT-2 (sodiumgl...
by Park Gi-taek  |  2017-05-04 13:30
라인
‘Korean drug market to grow twice faster than GDP until 2021’
Korea’s pharmaceutical market is likely to grow 4.4 percent on annual avera...
by Lee Hye-seon  |  2017-05-02 14:33
라인
FDA okays first drug for Batten disease
Biomarin Pharmaceutical won the go-ahead from the U.S. Food and Drug Admini...
by Constance Williams  |  2017-04-28 15:49
라인
JW Pharmaceutical worst of 10 major drugmakers for women to work in
In every election, presidential candidates have promised to shatter glass c...
by Nam Doo-hyun  |  2017-04-28 12:07
라인
FDA approves 1st treatment for liver cancer in decade
The U.S. Food and Drug Administration Thursday expanded the approved use of...
by Constance Williams  |  2017-04-28 11:25
라인
Boryung’s 1Q sales hit ₩99.8 billion
Boryung Pharmaceuticals보령제약 recorded sales of 99.8 billion won ($88.3 milli...
by Lee Hye-seon  |  2017-04-27 14:59
라인
How Daewoong released Korea’s 1st generic drug in US?
All eyes of Korean drugmakers are on Daewoong Pharmaceutical, as it has ach...
by Lee Hye-seon  |  2017-04-27 13:28
라인
Expectations rise about new bio drug going global
AFSTYLA, a hemophilia therapy developed by SK Chemicals SK케미칼이 jointly with...
by Lee Hye-seon  |  2017-04-26 18:06
라인
Customized subfertility therapy to debut in Korea
REKOVELLE (compound: follitropin delta), the personalized subfertility trea...
by Lee Hye-seon  |  2017-04-26 16:22
라인
FDA warns 14 firms against selling false cancer-curing products
The U.S. Food and Drug Administration (FDA) posted warning letters on Tuesd...
by Constance Williams  |  2017-04-26 10:49
라인
Samsung Bioepis wins first FDA approval for biosimilar drug
The U.S. Food and Drug Administration Friday approved Samsung Bioepis’ rheu...
by Marian Chu  |  2017-04-24 18:18
라인
Pharmacists oppose introduction of corporate-style drugstores
Koreans work hard. They are second-hardest working people among OECD nation...
by Constance Williams  |  2017-04-21 16:51
라인
Baxter allegedly forces workers to quit under disguise of advice
Baxter Korea, the Korean offshoot of the U.S.-based pharmaceutical company,...
by Marian Chu  |  2017-04-20 16:17
라인
Daewoong launches first generic antibiotic in US
Daewoong Pharmaceutical대웅제약 has launched its generic antibiotic “Meropenem”...
by Constance Williams  |  2017-04-19 18:03
라인
State auditors ‘fail to confirm Hanmi’s cover-up of clinical results’
The government’s top administrative watchdog has found Hanmi Pharmaceutical...
by Marian Chu  |  2017-04-18 15:23
라인
FDA stuns Eli-Lilly, Incyte by rejecting rheumatoid arthritis drug
Eli Lilly and Co. and Incyte Corp. said Friday that the U.S. Food and Drug ...
by Constance Williams  |  2017-04-17 17:17
라인
Cancer patients protest against Novartis Korea
Novartis Korea’s targeted anticancer treatment, Gleevec, is in danger of lo...
by Marian Chu  |  2017-04-17 15:04
라인
Korean firms stage ‘let’s-save-our drug’ drive
The “let’s-save-our drug” campaign -- initiated by the domestic medicine di...
by Lee Hye-seon  |  2017-04-14 15:30
라인
Hanmi preempts global incontinence drug market
Hanmi Pharma한미약품(CEOs Woo Jong-soo우종수 and Kwon Se-chang권세창) has grabbed ano...
by Lee Hye-seon  |  2017-04-12 18:37
여백
여백
여백
Back to Top